Healthcare
Live Price
Offline$7.39
+0.27% today
Window Change
-14.15%
Window
May 6, 2026 → Jun 24, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 34 bars · May 6, 2026 → Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Grifols, S.A. (GRFS) is a Healthcare stock with a market cap of $6.10B and listed on NASDAQ. The stock last traded around $7.39 and down 14.1% across the available one-year price window (May 6, 2026 → Jun 24, 2026). Baseline metrics include revenue growth of +0.2%, EPS growth of +147.8%, a dividend yield of 1.7%. What stands out right now is revenue +0.2%, EPS +147.8%, free cash flow +41.5% with operating margin 17.0% and ROIC 5.7%. The dividend is present but secondary, with a yield around 1.7%. Valuation is more restrained than many high-expectation growth names at P/E 15.3 and price/sales 0.8. Stock Foundry combines GRFS price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
GRFS is 14.07 pts behind over the shared 1Y window.
GRFS had 5.49 pts deeper max drawdown than SPY.
GRFS beat SPY in 0 of 1 calendar years shown and trailed in 1.
GRFS
-14.15%
Normalized return
SPY
-0.08%
S&P 500
Excess Return
-14.07 pts
Relative to SPY
GRFS Max Drawdown
-14.63%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for GRFS and SPY.
| Year | GRFS | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -14.15% | +6.71% | -20.86 pts | SPY |
| 2025 | — | +11.73% | -- | -- |
Unable to load analyst forecasts.
Timed out loading forecasts for GRFS
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.